Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717403 · ClinicalTrials.gov registry record · Phase 2
Effects of Social Networking on Chronic Disease Management in Arthritis
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT02717403: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT02717403 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02717403, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
Objectives: The overall goal of this study is to use the principles of chronic disease management to develop and test an online social networking intervention using the FB platform in a randomized controlled trial. Our specific objectives are as follows: Aim 1: To develop and establish an independent closed community in FB for patients with rheumatoid arthritis, providing an educational platform for disease self-management and the potential for engaging in social networking with peers (Phase 2). Objective 1. To beta test the features and navigation buttons and panels in the newly developed website and FB group. Objective 2. To evaluate the contents, ease of use and satisfaction with the newly developed website and FB group by patient advocates (consultants to the study) who participate as members of the Facebook community. Aim 2: To evaluate the efficacy of the FB community intervention combined with an educational website to improve patients' self-management (including knowledge, which is the primary outcome), decision making and patient-reported outcomes compared with the educational website alone (Phase 3). We hypothesize that participation in an online closed community offering evidence-based information combined with peer interaction and support will improve patients' knowledge.
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Facebook
- BEHAVIORAL Educational Website
- BEHAVIORAL Phone Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2016-04-07 |
| Est. Completion | 2023-06-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02717403
The ClinicalTrials.gov registry entry for NCT02717403 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT02717403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02717403 about?
NCT02717403 is a clinical study titled "Effects of Social Networking on Chronic Disease Management in Arthritis". Objectives: The overall goal of this study is to use the principles of chronic disease management to develop and test an online social networking intervention using the FB platform in a randomized controlled trial. Our specific objectives are as follows: Aim 1: To develop and establish an independ...
What is the current status of trial NCT02717403?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2016-04-07. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT02717403?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Facebook (BEHAVIORAL), Educational Website (BEHAVIORAL), Phone Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT02717403?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.